These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11012628)

  • 1. A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas(lprcg) mice.
    Zhang Y; Yasuda T; Wang CR; Yoshimoto T; Nagase H; Takamoto M; Tsubura A; Kimura M; Matsuzawa A
    Clin Exp Immunol; 2000 Oct; 122(1):124-32. PubMed ID: 11012628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of renal disease and lymphadenopathy in MRL-Fasp(lrcg)/Fas(lprcg) (MR-lpr(cg)) mice neonatally infected with mouse mammary tumor virus encoding superantigen strongly reactive with TCR Vbeta8.2 element.
    Matsuzawa A; Yasuda T; Zhang Y; Nagase H; Yoshimoto T; Kimura M; Tsubura A
    Viral Immunol; 2000; 13(3):297-311. PubMed ID: 11016595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
    Kikawada E; Lenda DM; Kelley VR
    J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephritogenicity of the lprcg gene on the MRL background.
    Kimura M; Ogata Y; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A
    Immunology; 1992 Jul; 76(3):498-504. PubMed ID: 1526655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
    Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
    J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity in mice bearing lprcg: a novel mutant gene.
    Kimura M; Matsuzawa A
    Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-C1q autoantibodies in murine lupus nephritis.
    Trouw LA; Seelen MA; Visseren R; Duijs JM; Benediktsson H; de Heer E; Roos A; van Kooten C; Daha MR
    Clin Exp Immunol; 2004 Jan; 135(1):41-8. PubMed ID: 14678263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production.
    Shi L; Bian Z; Chen CX; Guo YN; Lv Z; Zeng C; Liu Z; Zen K; Liu Y
    J Pathol; 2015 Nov; 237(3):285-95. PubMed ID: 26095930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive expression of lprcg in the heterozygous state on different genetic backgrounds.
    Ogata Y; Kimura M; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A
    Cell Immunol; 1993 Apr; 148(1):91-102. PubMed ID: 8495493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 drives IFN-gamma-dependent autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Tesch G; Kinoshita K; Maron R; Weiner HL; Kelley VR
    J Immunol; 1999 Dec; 163(12):6884-91. PubMed ID: 10586090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant role of Fas ligand-binding but defective Fas receptor (CD95) in lymph node hyperplasia composed of abnormal double-negative T cells.
    Matsuzawa A; Shimizu M; Takeda Y; Nagase H; Sayama K; Kimura M
    Immunology; 2002 Aug; 106(4):470-5. PubMed ID: 12153509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in
    Zhou Y; Chen H; Liu L; Yu X; Sukhova GK; Yang M; Kyttaris VC; Stillman IE; Gelb B; Libby P; Tsokos GC; Shi GP
    J Immunol; 2017 Mar; 198(5):1846-1854. PubMed ID: 28093526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological characterization of C3H mice congenic for Fas(lprcg), C3h/HeJ-Fas(lprcg)/Fas(lprcg).
    Yasuda T; Zhang Y; Nagase H; Kaneko T; Sayama K; Hashimoto H; Matsuzawa A
    Lab Anim; 2000 Jan; 34(1):46-55. PubMed ID: 10759366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci.
    Watson ML; Rao JK; Gilkeson GS; Ruiz P; Eicher EM; Pisetsky DS; Matsuzawa A; Rochelle JM; Seldin MF
    J Exp Med; 1992 Dec; 176(6):1645-56. PubMed ID: 1460423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.